The Nasdaq Narrowly avoided posting its worst January in history, with a 3.4% gain to end the month. But is the rally for real, or is there more trouble to come. Plus, biotech has been a big laggard in recent months, but one top analyst has names he thinks are ready to play catch-up. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
